Effects of Bulgarian red and white wines on primary hemostasis and experimental thrombosis in rats

Polish Journal of Pharmacology

Volumn 55, Issue 6, 2003, Pages 1089-1096

  Wollny, Tomasz ^a   Chabielska, Ewa ^a   Malinowska Zaprzałka, Małgorzata ^a   Nazarko, Joanna ^a   Rozmysłowicz Szermińska, Wioletta ^a   Buczko, Włodzimierz ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Hemostasis; Rat; Thrombosis; Wine

Indexed keywords

ALCOHOL; FIBRILLAR COLLAGEN; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROSTAGLANDIN; PROSTAGLANDIN INHIBITOR;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ARTERY THROMBOSIS; ARTICLE; BLEEDING TIME; CARDIOVASCULAR RISK; CONTROLLED STUDY; HEMOSTASIS; ISCHEMIC HEART DISEASE; MALE; NONHUMAN; NUTRITIONAL VALUE; RAT; RED WINE; THROMBOCYTE ADHESION; VEIN THROMBOSIS; WINE;

ADMINISTRATION, ORAL; ANIMALS; BLEEDING TIME; BULGARIA; DOSE-RESPONSE RELATIONSHIP, DRUG; EPOPROSTENOL; ETHANOL; HEMOSTASIS; INJECTIONS, INTRAVENOUS; MALE; NITRIC OXIDE; PLATELET ADHESIVENESS; RATS; RATS, WISTAR; THROMBOSIS; VENOUS THROMBOSIS; WINE;

EID: 1642543893     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Andrews R.K., Berndt M.C.: Adhesion-dependent signalling and the initiation of haemostasis and thrombosis. Histol. Histopathol., 1998, 13, 837-844.
2. Andriambeloson E., Kleschyov A.L., Muller B., Beretz A., Stocklet J.C., Andriantitohaina R.: Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta. Brit. J. Pharmacol., 1997, 120, 1053-1058.
3. Belleville J.: The French paradox: possible involvement of ethanol in the protective effect against cardiovascular diseases. Nutrition, 2002, 18, 173-177.
4. Benito S., Lopez D., Saiz M.P., Buxederas S., Sanchez J., Duig-Parellada P., Mitjavila M.T.: A flavonoid-rich diet increases nitric oxide production in rat aorta. Brit. J. Pharmacol., 2002, 135, 910-916.
5. Chabielska E., Kolpakov V., D'Adamo M.C., De Curtis A., Buczko W., Iacoviello L., Donati M.B.: Morphological and hemostatic changes in rats with abdominal arterial prosthesis. Thromb. Res., 1996, 82, 69-77.
6. De Caterina R., Libby P., Peng H.B., Thannickal V.J., Rajavastisth T.B., Gimbrone M.A. Jr., Shin W.S. Liao J.K.: Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest., 1995, 96, 60-68.
7. de Gaetano G., De Curtis A., di Castelnuovo A., Donati M.B., Iacoviello L. Rotondo S. : Antithrombotic effect of polyphenols in experimental models: a mechanism of reduced vascular risk by moderate wine consumption. Ann. NY Acad. Sci., 2002, 957, 174-188.
8. Dejana E., Villa S., de Gaetano G.: Bleeding time in rats: a comparison of different experimental conditions. Thromb. Haemost., 1982, 48, 108-111.
9. Demrow H.S., Slane P.R., Folts J.D.: Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation, 1995, 91, 1182-1188.
10. Donahue R.P., Abbott R.D.: Alcohol and haemorrhagic stroke. Lancet, 1986, 2, 515-516.
11. Elmer O., Goransson G., Zoucas E.: Impairment of primary hemostasis and platelet function after alcohol ingestion in man. Haemostasis, 1984, 14, 223-228.
12. EUROASPIRE II Study Group.: Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur. Heart J., 2001, 22, 554-572.
13. Ferrero M.E., Bertelli A.E., Fulgenzi A., Pellegatta F., Corsi M.M., Bonfrate M., Ferrara F., De Caterina R., Giovannini L., Bertelli A.: Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium. Amer. J. Clin. Nutr., 1998, 68, 1208-1214.
14. Flesch M., Schwarz A., Bohm M.: Effects of red and white wine on endothelium-dependent vasorelaxation of rat aorta and human coronary arteries. Amer. J. Physiol., 1998, 275, H1183-H1190.
15. Giles A.R.: Guidelines for the use of animals in biomedical research. Thromb. Haemost., 1987, 58, 1078-1084.
16. Gruszecki M., Rółkowski R., Pawlak R., Buczko W.: Propranolol prevents the development of venous thrombosis by a platelet-dependent mechanism. Pol. J. Pharmacol., 2001, 53, 5-10.
17. Haenen G.R., Bast A.: Nitric oxide radical scavenging of flavonoids. Meth. Enzymol., 1999, 301, 490-503.
18. Hornstra G., Vandelmans-Starrenburg A.: Induction of experimental arterial occlusive thrombi in rats. Atherosclerosis, 1972, 17, 369-382.
19. Kris-Etherton P.M., Keen C.L.: Evidence that the anti-oxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Curr. Opin. Lipidol., 2002, 13, 41-49.
20. Kubes P., Suzuki M., Granger D.N.: Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Nat. Acad. Sci. USA, 1991, 88, 4651-4655.
21. Lacoste L., Hung J., Lam J.Y.: Acute and delayed antithrombotic effects of alcohol in humans. Amer. J. Cardiol., 2001, 87, 82-85.
22. Landrault N., Poucheret P., Ravel P., Gasc F., Cros G., Teissedre P.L.: Antioxidant capacities and phenolics levels of French wines from different varieties and vintages. J. Agric. Food Chem., 2001, 49, 3341-3348.
23. Leger A.S., Cochrane A.L., Moore F.: Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet, 1979, 12, 1017-1020.
24. Leikert J.F., Rathel T.R., Wohlfart P., Cheynier V., Vollmar A.M., Dirsch V.M.: Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation, 2002, 106, 1614-1617.
25. Levi F., Lucchini F., Negri E., La Vecchia C.: Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart, 2002, 88, 119-124.
26. Olas B., Wachowicz B., Saluk-Juszczak J., Zieliński T.: Effect of resveratrol, a natural polyphenolic compound, on platelet activation induced by endotoxin or thrombin. Thromb. Res., 2002, 107, 141-145.
27. Pace-Asciak C.R., Hahn S., Diamandis E.P., Soleas G., Goldberg D.M.: The red wine phenolics transresveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin. Chim. Acta, 1995, 235, 207-219.
28. Pawlak D., Malczyk E., Darewicz J., Azzadin A., Buczko W.: Platelet serotonergic mechanisms in patients with cancer of the urinary bladder. Thromb. Res., 2000, 98, 367-374.
29. Pignatelli P., Pulcinelli F.M., Celestini A., Lenti L., Ghiselli A., Gazzaniaga P.P., Violi F.: The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide. Amer. J. Clin. Nutr., 2000, 72, 1150-1155.
30. Radomski M.W., Palmer R.M., Moncada S.: The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem. Biophys. Res. Commun., 1987, 148, 1482-1489.
31. Radomski M.W., Palmer R.M., Moncada S.: Characterization of the L-arginine: nitric oxide pathway in human platelets. Brit. J. Pharmacol., 1990, 101, 325-328.
32. Renaud S., de Lorgeril M.: Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet, 1992, 339, 1523-1526.
33. Reyers I., de Gaetano G., Donati M.B.: Venostasis-induced thrombosis in rat is not influenced by circulating platelet or leukocyte number. Agents Action., 1989, 28, 137-141.
34. Robak J., Gryglewski R.J.: Bioactivity of flavonoids. Pol. J. Pharmacol., 1996, 48, 555-564.
35. Rotondo S., Rajtar G., Manarini S., Celardo A., Rotilio D., de Gaetano G., Evangielista V., Cerletti C.: Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Brit. J. Pharmacol., 1998, 123, 1691-1699.
36. Schaub R.G., Simmons C.A., Koets M.H., Romano P.J., Steward G.J.: Early events in the formation of a venous thrombus following local trauma and stasis. Lab. Invest., 1984, 51, 218-224.
37. van Acker S.A., Tromp M.N., Haenen G.R., van der Vijgh W.J., Bast A.: Flavonoids as scavengers of nitric oxide radical. Biochem. Biophys. Res. Commun., 1995, 214, 755-759.
38. Wollny T., Aiello L., Di Tommaso D., Bellavia V., Rotilio D., Donati M.B., de Gaetano G., Iacoviello L.: Modulation of haemostatic function and prevention of experimental thrombosis by red wine in rats: a role for increased nitric oxide production Brit. J. Pharmacol., 1999, 127, 747-755.
39. Wollny T., Iacoviello L., Aiello L., Manarini S., Buczko W.: Administration of red wine inhibits venous thrombosis and prolongs bleeding time in rats. Thromb. Haemost., 1997, Suppl. S, P2773.
40. Wollny T., Iacoviello L., Buczko W., de Gaetano G., Donati M.B.: Prolongation of bleeding time by acute hemolysis in rats: a role for nitric oxide. Amer. J. Physiol., 1997, 272, H2875-H2884.
41. Zhao X., Gu Z., Attele A.S., Yuan C.S.: Effects of quercetin on the release of endothelin, prostacyclin and tissue plasminogen activator from human endothelial cells in culture. J. Ethnopharmacol., 1999, 67, 279-285.